Read Our Latest Issue Letters to the editor from the August 2019 issue of As a community oncologist, I enjoyed James DeGregori and Robert Gatenby's article "Darwin's Cancer Fix." Their approach to treating metastatic prostate cancer by managing its growth, rather than trying to kill all cancer cells, to avoid drug-resistant tumors is intriguing and deserves a large randomized phase III trial. But it is very important to remember that, biologically, cancers are extremely heterogeneous, and there are caveats to the principles the authors outline. This is a preview. Make a selection below to access this issue.Already have access? . Having trouble accessing this article? Please visit our page for more information Discover world-changing science. Explore our digital archive back to 1845, including articles by more than 150 Nobel Prize winners. Follow us Scientific american arabic (c) 2021 Scientific American, a Division of Springer Nature America, Inc. All Rights Reserved. Support our award-winning coverage of advances in science & technology. Already a subscriber? Subscribers get more award-winning coverage of advances in science & technology.